Learn More
OBJECTIVE To assess the efficacy and safety of two etanercept dose regimens for psoriasis treatment. METHODS Subjects were ≥18 years old with stable moderate-to-severe plaque psoriasis. Subjects(More)
OBJECTIVE To assess patient-reported outcomes (PRO) in patients with moderate-to-severe plaque psoriasis receiving continuous or paused etanercept treatment. METHODS In a multicentre European(More)
BACKGROUND Efficacy of biologic therapies for psoriasis has been demonstrated in randomized trials, but effectiveness in real-world settings has yet to be fully determined. OBJECTIVE To compare(More)